These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7450364

  • 21. [Use of encephabol in the combined therapy of chronic cerebral circulatory failure].
    Zinchenko VA.
    Vrach Delo; 1984 Aug; (8):36-8. PubMed ID: 6506608
    [No Abstract] [Full Text] [Related]

  • 22. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
    Ingelmo M, Vivancos J, Peri J, Balcells Gorina A.
    Rev Clin Esp; 1980 Dec 31; 159(6):399-402. PubMed ID: 6784197
    [No Abstract] [Full Text] [Related]

  • 23. [Immediate help is necessary in stroke. A survey of factors delaying therapy].
    Hårdemark HG, Könberg E.
    Lakartidningen; 1993 Jun 16; 90(24):2302-4. PubMed ID: 8316004
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [The therapeutic effect of kavain and magnesium orotate on traumatic and vascular brain lesions].
    Wenzel E.
    Wien Med Wochenschr; 1971 Mar 20; 121(12):226-36. PubMed ID: 5556378
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [The use of nimodipine in comatose patients with different types of cerebrovascular pathology].
    Alia G, Mattaliano A.
    Clin Ter; 1993 Oct 20; 143(4):295-301. PubMed ID: 8258263
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
    Gerin J.
    Curr Ther Res Clin Exp; 1969 Sep 20; 11(9):539-46. PubMed ID: 4980884
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Effect of cytidine monophosphate on organic syndromes of the brain].
    Otsuki S, Ninomiya K, Yamamoto M, Nakashima Y, Shutara M.
    No To Shinkei; 1966 Jul 20; 18(7):745-9. PubMed ID: 5953682
    [No Abstract] [Full Text] [Related]

  • 37. [Treatment of cerebrovascular insufficiency symptoms. Experiences with Instenon].
    Pillau H.
    Ther Ggw; 1969 Sep 20; 108(9):1292 passim. PubMed ID: 4392634
    [No Abstract] [Full Text] [Related]

  • 38. [The prevention of cerebral circulatory disorders in arterial hypertension].
    Britov AN, Manvelov LS.
    Ter Arkh; 1997 Sep 20; 69(1):38-43. PubMed ID: 9163048
    [No Abstract] [Full Text] [Related]

  • 39. [Prolonged treatment of coronary insufficiency with heparin in clarifying doses and essential phospholipids].
    Caruzzo C.
    Therapeutique; 1969 Apr 20; 45(4):413-9. PubMed ID: 5386074
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.